Heide L Ford Selected Research

Heide L Ford Research Topics

Disease

41	Neoplasms (Cancer) 03/2024 - 08/2003
20	Breast Neoplasms (Breast Cancer) 09/2023 - 04/2004
18	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2007
5	Carcinoma (Carcinomatosis) 10/2014 - 04/2004
3	Tics (Tic) 09/2023 - 07/2012
3	Carcinogenesis 04/2007 - 01/2004
2	Triple Negative Breast Neoplasms 09/2023 - 10/2014
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 08/2012
1	Medulloblastoma 12/2023
1	Inflammation (Inflammations) 09/2023
1	Rhabdomyosarcoma 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 11/2021
1	Adenocarcinoma of Lung 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Glioma (Gliomas) 06/2013
1	Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome) 04/2013
1	Bone Neoplasms (Bone Cancer) 08/2012
1	Lymphatic Metastasis 05/2012
1	Ovarian Neoplasms (Ovarian Cancer) 05/2012
1	Lymphoma (Lymphomas) 01/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2008

Drug/Important Bio-Agent (IBA)

13	Transcription Factors (Transcription Factor)IBA 01/2022 - 08/2003
12	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2011
10	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024 - 01/2013
8	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2023 - 04/2004
6	Messenger RNA (mRNA)IBA 06/2013 - 04/2004
4	LigandsIBA 01/2017 - 04/2007
4	Transforming Growth Factor beta (TGF-beta)IBA 07/2012 - 09/2009
3	Tyrosine (L-Tyrosine)FDA Link 12/2023 - 01/2018
3	Vascular Endothelial Growth Factor CIBA 01/2021 - 05/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 04/2007
2	RNA (Ribonucleic Acid)IBA 09/2023 - 05/2015
2	Amino Acids FDA Link 01/2017 - 04/2013
2	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 08/2012
2	Cyclin D1IBA 09/2009 - 08/2003
2	Cyclin A1IBA 04/2008 - 04/2004
1	InterferonsIBA 09/2023
1	Bone Marrow Stromal Antigen 2IBA 09/2023
1	Small Cytoplasmic RNAIBA 09/2023
1	IntegrinsIBA 01/2023
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	LuciferasesIBA 01/2022
1	indium-bleomycinIBA 01/2022
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	CaspasesIBA 01/2017
1	betaglycan (TGFBR3)IBA 05/2015
1	Protein Tyrosine PhosphatasesIBA 02/2015
1	AgarIBA 12/2014
1	Cadherins (E-Cadherin)IBA 12/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2014
1	ClaudinsIBA 10/2014
1	Superoxide DismutaseIBA 10/2014
1	AntioxidantsIBA 10/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2013
1	CytokinesIBA 09/2012
1	Phosphotransferases (Kinase)IBA 07/2012
1	Phenobarbital (Luminal)FDA Link 07/2012
1	Mitogen-Activated Protein KinasesIBA 07/2012
1	U 0126 (UO 126)IBA 07/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012
1	AZD 6244IBA 07/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2012
1	Antineoplastic Agents (Antineoplastics)IBA 03/2011
1	Drug CombinationsIBA 03/2011
1	Fas Ligand Protein (Fas Ligand)IBA 01/2011
1	Death Domain ReceptorsIBA 01/2011
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2011
1	Transforming Growth Factor-beta Type I ReceptorIBA 12/2010
1	beta CateninIBA 06/2010
1	1,2-cyclohexanediamine (dach)IBA 01/2008
1	CyclinsIBA 04/2007
1	AntibodiesIBA 04/2007
1	CCAAT-Enhancer-Binding Protein-betaIBA 08/2003
1	Interleukin-6 (Interleukin 6)IBA 08/2003

Therapy/Procedure

12	Therapeutics 01/2022 - 04/2007
2	Drug Therapy (Chemotherapy) 10/2014 - 08/2012